Just curious why would you think Rx has anything to do with it? They were up about 50% WoW last week per symphony...
I'm guessing the huge short interest and the general biotech malaise sending it down (although it's silly to insinuate ENTA was in any sort of bubble).
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.